Office of the Federal Register, National Archives and Records Administration. 79 FR 49661 - Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II. Office of the Federal Register, National Archives and Records Administration. August21, 2014. Accessed December 17, 2021. https://www.govinfo.gov/app/details/FR-2014-08-22/2014-19922
2.
RajiMAKuoYFAdhikariDBaillargeonJGoodwinJS. Decline in opioid prescribing after federal rescheduling of hydrocodone products. Pharmacoepidemiol Drug Saf. 2018;27(5):513-519. doi:10.1002/pds.4376
3.
LiuYBakerOSchuurJDWeinerSG. Effects of rescheduling hydrocodone on opioid prescribing in Ohio. Pain Med. 2020;21(9):1863-1870. doi:10.1093/pm/pnz210
4.
JonesCMLuriePGThrockmortonDC. Effect of US Drug Enforcement Administration’s rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing. JAMA Intern Med. 2016;176(3):399-402. doi:10.1001/jamainternmed.2015.7799
5.
NeumanMDHennessySSmallDS, et al. Drug Enforcement Agency 2014 hydrocodone rescheduling rule and opioid dispensing after surgery. Anesthesiology. 2020;132(5):1151-1164. doi:10.1097/ALN.0000000000003188
6.
HabboucheJLeeJSteigerR, et al. Association of hydrocodone schedule change with opioid prescriptions following surgery. JAMA Surg. 2018;153(12):1111-1119. doi:10.1001/jamasurg.2018.2651
